Loading clinical trials...
Loading clinical trials...
We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Environmental Health Sciences (NIEHS)
NCT07032727 · Targeted Therapy, IDH1-Mutated Malignancies, and more
NCT07288580 · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
NCT06313437 · Acute Myeloid Leukemia, AML, Adult, and more
NCT01443468 · Li-Fraumeni Syndrome, Neoplasms, and more
NCT07329257 · Baker Gordon Syndrome, Rare Neurodevelopmental Conditions, and more
NIEHS, Research Triangle Park
Research Triangle Park, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions